|
1
|
Yang JD, Hainaut P, Gores GJ, Amadou A,
Plymoth A and Roberts LR: A global view of hepatocellular
carcinoma: Trends, risk, prevention and management. Nat Rev
Gastroenterol Hepato. l16:589–604. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Colombet M, Soerjomataram I,
Parkin DM, Piñeros M, Znaor A and Bray F: Cancer statistics for the
year 2020: An overview. Int J Cancer. Apr 5–2021.(Epub ahead of
print). doi: 10.1002/ijc.33588. View Article : Google Scholar
|
|
3
|
Wang G, Wang Q, Liang N, Xue H, Yang T,
Chen X, Qiu Z, Zeng C, Sun T, Yuan W, et al: Oncogenic driver genes
and tumor microenvironment determine the type of liver cancer. Cell
Death Dis. 11:3132020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lokau J, Schoeder V, Haybaeck J and
Garbers C: Jak-stat signaling induced by interleukin-6 family
cytokines in hepatocellular carcinoma. Cancers (Basel).
11:17042019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chung MW, Ha SY, Choi JH, Park HJ, Myung
DS, Cho SB, Lee WS, Kim JW, Oh HH and Joo YE: Cardiac tamponade
after radiofrequency ablation for hepatocellular carcinoma: Case
report and literature review. Medicine (Baltimore). 97:e135322018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang YM, Kim SY and Seki E: Inflammation
and liver cancer: Molecular mechanisms and therapeutic targets.
Semin Liver Dis. 39:26–42. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Niu ZS, Niu XJ, Wang WH and Zhao J: Latest
developments in precancerous lesions of hepatocellular carcinoma.
World J Gastroenterol. 22:3305–3314. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng T, Wang J, Jiang H and Liu LX: Hippo
signaling in oval cells and hepatocarcinogenesis. Cancer Lett.
302:91–99. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen Y and Cao DL: Hepatocellular
carcinoma stem cells: Origins and roles in hepatocarcinogenesis and
disease progression. Front Biosci (Elite Ed). 4:1157–1169. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen JM, Chen L, Zern MA, Theise ND, Diehl
AM, Liu P and Duan YY: The diversity and plasticity of adult
hepatic progenitor cells and their niche. Liver Int. 37:1260–1271.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu RH, Zheng LY, He DL, Meng J, Xia LP,
Hao XB and Zhang ZZ: Profiling of differentially expressed
microRNAs (miRNAs) during differentiation of rat hepatic oval cells
(HOCs) into hepatocellular carcinoma (HCC) cells. Clin Transl
Oncol. 17:230–237. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lecarpentier Y, Schussler O, Hebert JL and
Vallee A: Multiple targets of the canonical WNT/β-catenin signaling
in cancers. Front Oncol. 9:12482019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vilchez V, Turcios L, Marti F and Gedaly
R: Targeting Wnt/β-catenin pathway in hepatocellular carcinoma
treatment. World J Gastroenterol. 22:823–832. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gong S, Qu X, Yang S, Zhou S, Li P and
Zhang Q: RFC3 induces epithelialmesenchymal transition in lung
adenocarcinoma cells through the Wnt/β-catenin pathway and
possesses prognostic value in lung adenocarcinoma. Int J Mol Med.
44:2276–2288. 2019.PubMed/NCBI
|
|
15
|
Cruz-Lozano M, Gonzalez-Gonzalez A,
Marchal JA, Muñoz-Muela E, Molina MP, Cara FE, Brown AM,
García-Rivas G, Hernández-Brenes C, Lorente JA, et al:
Hydroxytyrosol inhibits cancer stem cells and the metastatic
capacity of triple-negative breast cancer cell lines by the
simultaneous targeting of epithelial-to-mesenchymal transition,
Wnt/β-catenin and TGFβ signaling pathways. Eur J Nutr.
58:3207–3219. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang Y and Lin Y, Wu Y, Zeng J, Huang M,
Guo S, Luo W, Lin H and Lin Y: Molecular mechanisms of the
inhibitory effects of jiangu granule-containing serum on
RANKL-induced osteoclastogenesis. Mol Med Rep. 16:8420–8426. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bi YH, Han WQ, Li RF, Wang YJ, Du ZS, Wang
XJ and Jiang Y: Signal transducer and activator of transcription 3
promotes the Warburg effect possibly by inducing pyruvate kinase M2
phosphorylation in liver precancerous lesions. World J
Gastroenterol. 25:1936–1949. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-(Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shang W, Adzika G, Li Y, Huang Q, Ding N,
Chinembiri B, Rashid MSI and Machuki JO: Molecular mechanisms of
circular RNAs, transforming growth factor-beta, and long noncoding
RNAs in hepatocellular carcinoma. Cancer Med. 8:6684–6699. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hilmi M, Neuzillet C, Calderaro J, Lafdil
F, Pawlotsky JM and Rousseau B: Angiogenesis and immune checkpoint
inhibitors as therapies for hepatocellular carcinoma: Current
knowledge and future research directions. J Immunother Cancer.
7:3332019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chao J, Zhao S and Sun H:
Dedifferentiation of hepatocellular carcinoma: Molecular mechanisms
and therapeutic implications. Am J Transl Res. 12:2099–2109.
2020.PubMed/NCBI
|
|
22
|
Yu XT, Wang PY, Shi ZM, Dong K, Feng P,
Wang HX and Wang XJ: Urotensin-II-mediated reactive oxygen species
generation via NADPH oxidase pathway contributes to hepatic oval
cell proliferation. PLoS One. 10:e01444332015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu DB and Tang H: Advances in the study of
cirrhosis and precancerous lesions of liver cancer. Zhonghua Gan
Zang Bing Za Zhi. 27:483–486. 2019.(In Chinese). PubMed/NCBI
|
|
24
|
Xu RH, Zheng LY, He DL, Meng J, Xia LP,
Hao XB and Zhang ZZ: Retraction note to: Profiling of
differentially expressed microRNAs (miRNAs) during differentiation
of rat hepatic oval cells (HOCs) into hepatocellular carcinoma
(HCC) cells. Clin Transl Oncol. 17:9352015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu J, Ruan B, You N, Huang Q, Liu W, Dang
Z, Xu W, Zhou T, Ji R, Cao Y, et al: Downregulation of miR-200a
induces EMT phenotypes and CSC-like signatures through targeting
the beta-catenin pathway in hepatic oval cells. PLoS One.
8:e794092013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Perugorria MJ, Olaizola P, Labiano I,
Esparza-Baquer A, Marzioni M, Marin JJG, Bujanda L and Banales JM:
Wnt-beta-catenin signalling in liver development, health and
disease. Nat Rev Gastroenterol Hepatol. 16:121–136. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang JL, Fu YP, Gan W, Liu G, Zhou PY,
Zhou C, Sun BY, Guan RY, Zhou J, Fan J, et al: Hepatic stellate
cells promote the progression of hepatocellular carcinoma through
microRNA-1246-RORα-wnt/β-catenin axis. Cancer Lett. 476:140–151.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li N, Wei L, Liu X, Bai HJ, Ye Y, Li D, Li
N, Baxa U, Wang Q, Lv L, et al: A frizzled-like cysteine-rich
domain in glypican-3 mediates wnt binding and regulates
hepatocellular carcinoma tumor growth in mice. Hepatology.
70:1231–1245. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wei W, Chua MS, Grepper S and So SK:
Blockade of Wnt-1 signaling leads to anti-tumor effects in
hepatocellular carcinoma cells. Mol Cancer. 8:762009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fu X, Zhu X, Qin F, Zhang Y, Lin J, Ding
Y, Yang Z, Shang Y, Wang L, Zhang QX and Gao Q: Linc00210 drives
Wnt/β-catenin signaling activation and liver tumor progression
through CTNNBIP1-dependent manner. Mol Cancer. 17:732018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Monga SP: β-catenin signaling and roles in
liver homeostasis, injury, and tumorigenesis. Gastroenterology.
148:1294–1310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Doumpas N, Lampart F, Robinson MD, Lentini
A, Nestor C, Cantù C and Basler K: TCF/LEF dependent and
independent transcriptional regulation of Wnt/beta-catenin target
genes. EMBO J. 38:e988732019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang TW, Gao YH, Ma SY, Qiang W and Li ZF:
Low-grade slightly elevated and polypoid colorectal adenomas
display differential beta-catenin-TCF/LEF activity, c-Myc, and
cyclin D1 expression. World J Gastroenterol. 23:3066–3076. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rana MA, Ijaz B, Daud M, Tariq S, Nadeem T
and Husnain T: Interplay of Wnt β-catenin pathway and miRNAs in HBV
pathogenesis leading to HCC. Clin Res Hepatol Gastroenterol.
43:373–386. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yan JS, Zhou JH and Cheng LB: Effect of
Kangxian ruangan granule on hepatic fibrosis induced by
tetrachloromethane and ethanol in rats. Chinese Journal of
Integrated Traditional and Western Medicine on Liver Disease.
27:40–41. 2017.
|
|
36
|
Zhang CZ, Yan HM and Wang L: 31 cases of
liver cirrhosis treated with Kangxian ruangan granule. Chinese
Journal of Integrated Traditional and Western Medicine on Liver
Disease. 2:19–20. 1999.(In Chinese).
|
